Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine for postoperative delirium prevention in elderly hip surgery patients
ChiCTR2600135081Phase 4Not yet recruiting
- Sponsor
- Jinjiang Municipal Hospital
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative delirium (POD) comparing Dexmedetomidine group with Placebo group (2 arms). Primary endpoint: Incidence of postoperative delirium. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2600135081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135081.